# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Julius Caesar (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC001-SYN
- Date: 2026-08-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucius Fairbanks-Okonkwo, MD
- Calendar frame: modern shifted

## What we are working on

- Six days ago he collapsed at a long outdoor ceremony after a strange rising feeling, with jerking of both arms, a bitten tongue, and twenty minutes of confusion; it is his third spell in eighteen months, and he wants to know why he collapses and whether it will happen again in public **S**
- He wants to keep working, travelling, speaking, and riding **S**
- He is frustrated at being told not to drive **S**

## Your goals

- Cause of the spells established and explained to him by the neurology visit. Target: 2026-08-18. Recorded outcome: Focal epilepsy with a structural vascular cause, from a chronic left temporal cortical infarct; syncope and transient ischemic attack judged unlikely. **S**
- No seizures on levetiracetam through the ten-week review. Target: 2026-10-27. Recorded outcome: No seizure or spell since levetiracetam was started ten weeks ago. **S**
- Office blood pressure below 130/80 mmHg. Target: 2026-10-27. Recorded outcome: 124/76 mmHg on lisinopril 10 mg and amlodipine 5 mg. **S**
- LDL cholesterol below 70 mg/dL on a high-intensity statin. Target: 2026-10-27. Recorded outcome: LDL 68 mg/dL after ten weeks of atorvastatin 80 mg. **S**
- No driving, swimming alone, or riding alone while the seizure-free period is counted, with a written seizure action plan for his staff. Target: 2026-10-27. Recorded outcome: Not driving; a driver and a riding companion arranged; seizure action plan given to his staff. **S**

## What we agreed to do

- Work-up of transient loss of consciousness: witness account, orthostatic vital signs, 12-lead ECG today, a 14-day ambulatory ECG patch from tomorrow, blood count, electrolytes, calcium, glucose, kidney and liver tests, HbA1c, lipids, and TSH; EEG and MRI of the brain with diffusion-weighted and epilepsy-protocol sequences; CT angiography of the head and neck; transthoracic echocardiogram. Guideline: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017); 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021) **S**
- Neurology consultation: is this epilepsy, syncope, or transient ischemic attack; review of the EEG, MRI, and vascular imaging; whether to start an antiseizure medicine and which; stroke prevention; and driving. Guideline: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology (2017) **S**
- Seizure safety from today: no driving until a seizure-free period set by state law and his neurologist; showers rather than baths; no swimming or riding alone; no climbing to heights; regular sleep of at least seven hours; a written seizure action plan for his staff, including when to call emergency services. Guideline: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015) **S**
- Blood pressure: lisinopril 10 mg daily from today; home blood pressure log twice daily; potassium and creatinine in two weeks; target below 130/80 mmHg. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, hypertension, and hyperlipidemia monographs (2026) **S**
- Antiseizure medicine: levetiracetam 500 mg twice daily, with teaching about irritability, low mood, and drowsiness; a seizure diary; no missed doses. Guideline: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018) **S**
- Secondary stroke prevention for the cortical infarct: aspirin 81 mg daily, atorvastatin 80 mg at bedtime with a lipid panel at 4 to 12 weeks (LDL target below 70 mg/dL), blood pressure below 130/80 mmHg with a second drug if needed, a home sleep apnea test, and a further four weeks of ambulatory rhythm monitoring (more than 30 days in all) for occult atrial fibrillation. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2017); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, hypertension, and hyperlipidemia monographs (2026) **S**
- Lifestyle: Mediterranean-style diet with sodium below 2.3 g a day; aerobic activity at least 150 minutes a week; alcohol kept at his present low level; no tobacco. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, hypertension, and hyperlipidemia monographs (2026) **S**
- Mood and cognition after the diagnosis: PHQ-9 four weeks after starting levetiracetam and then periodically; MoCA in the first months after the infarct was found. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, hypertension, and hyperlipidemia monographs (2026) **S**
- Adult prevention plan: influenza, pneumococcal, and recombinant zoster vaccines; hepatitis C, hepatitis B, and HIV screening; colonoscopy for colorectal cancer screening; eye examination; PSA discussion at 55. Guideline: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026) **S**

## Follow-up

- 2026-08-04: Urgent visit after a witnessed collapse with jerking and confusion, the third spell in eighteen months: history, examination, ECG, tests, cardiac monitor, seizure safety, and neurology referral **S**
- 2026-08-18: Two-week follow-up with the neurology consultation: EEG, MRI, vascular imaging, echocardiogram, and monitor reviewed; diagnosis made and treatment started **S**
- 2026-09-15: Four-week review of levetiracetam, blood pressure, the second rhythm monitor, mood, and cognition **S**
- 2026-10-06: Adult preventive visit **S**
- 2026-10-27: Ten-week review: seizure control, lipids on atorvastatin, blood pressure, and driving and safety **S**

This teaching document does not replace care from a qualified clinician.
